Gut Robert

SEC Form 4 insider trading activity

Gut Robert has filed 3 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jun 12, 2026.

On the most recent filing, Gut Robert is listed as Director at uniQure N.V. Inside the rolling window, Gut Robert reported no open-market purchases and 3 open-market sales totaling $901K in QURE. The largest disclosed transaction in the window is a sale of 25,613 QURE shares on Jan 12, 2026, worth $630K.

Companies traded

Other insiders at QURE

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$901K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
QURESale$197KJun 12SEC ↗
QURESale$74KJun 12SEC ↗
QURESale$630KJan 14SEC ↗
Showing 1–3 of 3
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Nov 6, 2025QURESale$426K
Nov 6, 2025QURESale$431K
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Gut Robert made?

Gut Robert has filed 3 SEC Form 4 filings (13 transaction rows) across 1 company since 2025.

Which companies does Gut Robert trade?

Gut Robert has filed SEC Form 4 disclosures for 1 company, including QURE.

When was Gut Robert's most recent SEC Form 4 filing?

Gut Robert's most recent SEC Form 4 filing on Tracefour is dated Jun 12, 2026.

What is Gut Robert's total buy and sell value in the current window?

Inside the rolling retention window, Gut Robert bought $0 and sold $901K based on SEC Form 4 filings.

What was Gut Robert's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 25,613 QURE shares on 2026-01-12, worth $630K, per SEC Form 4 filings.